Tag: Good Manufacturing Practice (GMP)

Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance

Posted on By digi

Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance Proven Strategies for Achieving and Sustaining Schedule M (Revised) GMP Compliance Introduction to Schedule M (Revised) GMP Compliance Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, outlines comprehensive Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of pharmaceutical products…

Read More “Best Practices for Achieving and Maintaining Schedule M (Revised) GMP Compliance” »

SCHEDULE - M - Revised

Best Practices for Ensuring NMPA GMP Compliance in China

Posted on By digi

Best Practices for Ensuring NMPA GMP Compliance in China Best Practices for Ensuring NMPA GMP Compliance in China Introduction to NMPA GMP and Compliance in China In the pharmaceutical industry, Good Manufacturing Practices (GMP) are essential for ensuring that products are consistently produced and controlled according to quality standards. In China, the National Medical Products…

Read More “Best Practices for Ensuring NMPA GMP Compliance in China” »

NMPA GMP Guidelines

Best Practices for Ensuring PMDA GMP Compliance in Japan

Posted on By digi

Best Practices for Ensuring PMDA GMP Compliance in Japan Best Practices for Ensuring PMDA GMP Compliance in Japan Introduction to PMDA GMP Compliance Good Manufacturing Practices (GMP) are essential to ensuring that pharmaceutical products are consistently produced and controlled to meet quality standards. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA) enforces GMP regulations…

Read More “Best Practices for Ensuring PMDA GMP Compliance in Japan” »

PMDA GMP Guidelines

How TGA GMP Guidelines Help with the Stability and Shelf Life of Pharmaceuticals

Posted on By digi

How TGA GMP Guidelines Help with the Stability and Shelf Life of Pharmaceuticals Ensuring Pharmaceutical Stability and Shelf Life with TGA GMP Guidelines Introduction to Stability and Shelf Life in Pharmaceuticals Pharmaceutical stability and shelf life are critical for ensuring the safety, efficacy, and quality of medicines over their intended use period. The Therapeutic Goods…

Read More “How TGA GMP Guidelines Help with the Stability and Shelf Life of Pharmaceuticals” »

TGA GMP Guidelines

How EMA GMP Standards Support Drug Manufacturing for Export to EU Markets

Posted on By digi

How EMA GMP Standards Support Drug Manufacturing for Export to EU Markets Ensuring Compliance for Drug Exports to the EU with EMA GMP Standards Introduction to EMA GMP Standards and Drug Exports The European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)) serve as a critical regulatory framework for pharmaceutical manufacturers aiming to export drugs to…

Read More “How EMA GMP Standards Support Drug Manufacturing for Export to EU Markets” »

EMA GMP Guidelines

How to Stay Compliant with MHRA GMP Guidelines in UK Pharmaceutical Operations

Posted on By digi

How to Stay Compliant with MHRA GMP Guidelines in UK Pharmaceutical Operations Maintaining Compliance with MHRA GMP Guidelines in Pharmaceutical Operations Introduction to MHRA GMP Compliance The Medicines and Healthcare products Regulatory Agency (MHRA) enforces Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of pharmaceutical products in the UK. Compliance with MHRA…

Read More “How to Stay Compliant with MHRA GMP Guidelines in UK Pharmaceutical Operations” »

MHRA GMP Guidelines

WHO GMP and the Role of Documentation and Record-Keeping

Posted on By digi

WHO GMP and the Role of Documentation and Record-Keeping The Critical Role of Documentation and Record-Keeping in WHO GMP Compliance Introduction to Documentation in WHO GMP Documentation and record-keeping are cornerstones of the World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) framework. They ensure traceability, accountability, and compliance in pharmaceutical manufacturing. Proper documentation serves as…

Read More “WHO GMP and the Role of Documentation and Record-Keeping” »

WHO GMP Guidelines

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil

Posted on By digi

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil Introduction to ANVISA GMP and Pharmaceutical Contamination The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory authority responsible for overseeing the safety, efficacy, and quality of pharmaceutical products. One of the primary ways ANVISA ensures drug safety…

Read More “How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How TGA GMP Affects Pharmaceutical Manufacturing Risk Management

Posted on By digi

How TGA GMP Affects Pharmaceutical Manufacturing Risk Management The Role of TGA GMP in Pharmaceutical Risk Management Introduction to TGA GMP and Risk Management Pharmaceutical manufacturing is inherently complex, involving numerous processes, raw materials, and regulatory requirements. Ensuring product safety, efficacy, and quality requires effective risk management strategies. The Therapeutic Goods Administration (TGA) enforces stringent…

Read More “How TGA GMP Affects Pharmaceutical Manufacturing Risk Management” »

TGA GMP Guidelines

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars

Posted on By digi

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars Ensuring Quality and Compliance in the Manufacture of Biologics and Biosimilars Under Schedule M (Revised) GMP Introduction to Biologics, Biosimilars, and Schedule M (Revised) Biologics and biosimilars are among the most advanced pharmaceutical products, offering targeted treatments for diseases such as cancer, autoimmune disorders,…

Read More “Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars” »

SCHEDULE - M - Revised